Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies
Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies have?
Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies has 30 citations in the OpenAlex counts ScholarIQ stores.
When was Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies published?
Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies has 2018 year in the ScholarIQ index.
What is the open-access status of Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies?
Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies has bronze oa status in the ScholarIQ index.
What is the DOI of Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies?
The DOI for Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies is on the source record.
What is the PMID of Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies?
The PMID for Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies is on the source record.
What is the OpenAlex record for Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies?
The OpenAlex for Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies is on the source record.